轨道血液瘤治疗 - 一个回顾性研究
Bartosz Bielecki-Kowalski1, Natalia Bielecka-Kowalska2, Marek Jaxa-Kwiatkowski3
1Department of Maxillofacial Surgery, Medical University of Lodz, 113 Żeromskiego St., 90-549 Lodz, Poland.
Journal of clinical medicine
|October 16, 2024
概括
轨道血液瘤引起的轨道腔综合征 (OCS) 很少见,但严重. 迅速的外科干预至关重要,因为延迟显著恶化了患者的结果,突出了对标准化OCS管理协议的需求.
科学领域:
- 眼科医生 眼科 眼科
- 面外科手术 面外科手术
- 创伤外科 手术 创伤外科
背景情况:
- 轨道血液瘤,包括骨下和骨后类型,在轨道创伤和手术后很常见.
- 虽然大多数轨道血液瘤在没有干预的情况下消失,但很小的百分比 (0.5-1%) 可能导致轨道分区综合征 (OCS).
- 由于快速增加眼内压力,OCS构成严重风险,可能在60-100分钟内导致视神经和视网膜缺血.
研究的目的:
- 以回顾分析导致OCS的轨道血液瘤病例.
- 评估与OCS相关的临床相关性和结果.
- 评估OCS手术管理方案的疗效.
主要方法:
- 在波兰 (2009-2022) 的口外科部门治疗OCS的18名患者的回顾性分析.
- 评估患者的人口统计,血瘤特征,骨折存在,凝血参数 (APTT,INR) 和视觉功能.
- 分析手术干预的时间,类型和术后结果,即时和一个月后的随访.
主要成果:
- 在血瘤大小和患者年龄,视力障碍严重程度和瞳孔反应之间发现了显著的相关性.
- 严重的初始症状和较大的血瘤与较差的立即和长期术后结果有关.
- 延迟诊断和手术干预,平均46小时,是常见的,只有一个患者在关键的100分钟窗口内进行手术.
结论:
- 这项研究支持目前关于轨道血液瘤和OCS管理的知识.
- 拟议的外科手术方案与现有的最佳实践保持一致.
- 小规模的研究限制了证实OCS和抗凝药等相关性的能力;及时诊断和干预对于有利的结果至关重要.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...